microdosing with glp 1 GLP-1s: Risks & Considerations How microdosing GLP-1 drugs became

Similar to IGF-I, IGF-II is also important for muscle growth and differentiation

GLP-1 (Glucagon-Like Peptide-1) receptor agonists are a class of medications designed to mimic the action of the natural GLP-1 hormone in the body

Abnormal IGF-1 and GH levels have been proposed to play a key role in obesity [130, 240, 241]

Few nutrition experts would refute a food first approach to optimizing human health

In a clinical trial in 13 subjects with type 2 diabetes, participants consumed a high-AGE meal before and after a 3-day course of benfotiamine, 1050 mg per day

This therapy is commonly considered when: Weight management has been difficult despite lifestyle efforts Blood sugar or metabolic markers require clinical support Appetite regulation is a concern Ongoing provider monitoring is preferred Men receiving care at our Rochester clinic are evaluated individually to ensure GLP-1 therapy aligns with their health profile and treatment goals